Biotech | July 16, 2022
Enveric Biosciences advances drug development for mental health indications
Advancing to IND-enabling studies with multiple drug candidates
Advancing to IND-enabling studies with multiple drug candidates
Syngene's collaboration with Zoetis started in 2011
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
States were also strongly advised to strictly monitor epidemiological profile of admitted COVID patients
Subscribe To Our Newsletter & Stay Updated
